CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 69513-69698 JSONTXT

{"project":"CORD-19-SciBite-sentences","denotations":[{"id":"T774","span":{"begin":0,"end":185},"obj":"http://purl.obolibrary.org/obo/HP0040078"},{"id":"T779","span":{"begin":0,"end":185},"obj":"http://purl.obolibrary.org/obo/GO0030424"},{"id":"T785","span":{"begin":0,"end":185},"obj":"https://id.nlm.nih.gov/mesh/D013119"},{"id":"T788","span":{"begin":0,"end":185},"obj":"https://id.nlm.nih.gov/mesh/D003711"}],"attributes":[{"id":"A774","pred":"class","subj":"T774","obj":"HPO"},{"id":"A779","pred":"class","subj":"T779","obj":"GOONTOL"},{"id":"A785","pred":"class","subj":"T785","obj":"INDICATION"},{"id":"A788","pred":"class","subj":"T788","obj":"INDICATION"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T102","span":{"begin":0,"end":185},"obj":"Sentence"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T344","span":{"begin":0,"end":185},"obj":"Sentence"},{"id":"TextSentencer_T344","span":{"begin":0,"end":185},"obj":"Sentence"},{"id":"T9415","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"Epistemic_Statements","denotations":[{"id":"T151","span":{"begin":0,"end":185},"obj":"Epistemic_statement"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T195","span":{"begin":94,"end":115},"obj":"Disease"},{"id":"T196","span":{"begin":166,"end":184},"obj":"Disease"},{"id":"T197","span":{"begin":178,"end":184},"obj":"Disease"}],"attributes":[{"id":"A195","pred":"mondo_id","subj":"T195","obj":"http://purl.obolibrary.org/obo/MONDO_0002562"},{"id":"A196","pred":"mondo_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/MONDO_0043797"},{"id":"A197","pred":"mondo_id","subj":"T197","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T96","span":{"begin":94,"end":107},"obj":"Phenotype"}],"attributes":[{"id":"A96","pred":"hp_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T146","span":{"begin":11,"end":17},"obj":"Body_part"},{"id":"T147","span":{"begin":74,"end":80},"obj":"Body_part"},{"id":"T148","span":{"begin":166,"end":177},"obj":"Body_part"}],"attributes":[{"id":"A146","pred":"uberon_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"},{"id":"A147","pred":"uberon_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"},{"id":"A148","pred":"uberon_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/UBERON_0002240"}],"text":"Therefore, myelin reactive antibodies might be useful not only to promote myelin repair after demyelinating disease but also for the treatment of axonal damage after spinal cord injury."}